KPV — compounding legality overview

Tripeptide anti-inflammatory

Common names: Lys-Pro-Val

PeptSense tracks KPV across federal 503A Bulks List chain steps, PCAC advisory context, and state board positions. Status is never inferred from forums or marketing sites — only published citations with effective dates.

Federal 503A snapshot (illustrative)

Latest published federal event for 503A compounding pharmacies. Sign in for your licensed states and facility type.

Summary

Honest curation baseline (2026-08-01): no confident Bulks List / USP / approved-component chain step assigned for KPV in this pass. Unclear until a human verifies a substance-specific citation. Not a legal determination.

Citation

FDA — 503A bulk drug substances page

Effective

Aug. 1, 2026

Not a legal determination. Replace placeholder citations during curation.

Run a full lookup

Get federal + state lanes, chain steps, printable answer cards, and compliance documents for the states you license in.